CN114177217A - Traditional Chinese medicine composition for treating cold-coagulation and blood stasis type dysmenorrhea and preparation method - Google Patents
Traditional Chinese medicine composition for treating cold-coagulation and blood stasis type dysmenorrhea and preparation method Download PDFInfo
- Publication number
- CN114177217A CN114177217A CN202111526549.0A CN202111526549A CN114177217A CN 114177217 A CN114177217 A CN 114177217A CN 202111526549 A CN202111526549 A CN 202111526549A CN 114177217 A CN114177217 A CN 114177217A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- blood
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 206010013935 Dysmenorrhoea Diseases 0.000 title claims abstract description 38
- 208000005171 Dysmenorrhea Diseases 0.000 title claims abstract description 37
- 210000004369 blood Anatomy 0.000 title claims abstract description 25
- 239000008280 blood Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 238000005345 coagulation Methods 0.000 title claims abstract description 10
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 14
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 14
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 13
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 13
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 13
- 241000207925 Leonurus Species 0.000 claims abstract description 13
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 13
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 13
- 210000002826 placenta Anatomy 0.000 claims abstract description 13
- 241000488974 Loranthus Species 0.000 claims abstract description 10
- 230000003071 parasitic effect Effects 0.000 claims abstract description 10
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 9
- 235000006533 astragalus Nutrition 0.000 claims abstract description 9
- 244000116484 Inula helenium Species 0.000 claims abstract description 7
- 235000002598 Inula helenium Nutrition 0.000 claims abstract description 7
- 241000427159 Achyranthes Species 0.000 claims abstract description 6
- 240000001638 Scurrula parasitica Species 0.000 claims abstract description 3
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 20
- 208000024891 symptom Diseases 0.000 abstract description 13
- 238000010792 warming Methods 0.000 abstract description 7
- 210000004291 uterus Anatomy 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 240000000031 Achyranthes bidentata Species 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 10
- 230000005906 menstruation Effects 0.000 description 9
- 208000004998 Abdominal Pain Diseases 0.000 description 8
- 241000212314 Foeniculum Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000008539 xiaoyao Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating cold-coagulation and blood-stasis type dysmenorrhea and a preparation method thereof, wherein the traditional Chinese medicine composition for treating cold-coagulation and blood-stasis type dysmenorrhea comprises the following components in parts by weight: 5-11 parts of motherwort, 3-9 parts of herba lycopi, 2-8 parts of costustoot, 2-6 parts of achyranthes root, 4-10 parts of fennel, 3-7 parts of cinnamon, 3-5 parts of radix angelicae pubescentis, 4-9 parts of human placenta, 3-7 parts of astragalus mongholicus, 3-7 parts of codonopsis pilosula, 2-5 parts of parasitic loranthus and 1-5 parts of ligusticum wallichii. The invention relates to the technical field of traditional Chinese medicines, and particularly provides a traditional Chinese medicine composition for treating cold-coagulation and blood-stasis type dysmenorrhea and a preparation method thereof, wherein motherwort, herba lycopi, elecampane and achyranthes bidentata with functions of activating blood and removing stasis are adopted to be mutually compatible with fennel, cinnamon and radix angelicae pubescentis with functions of dispelling cold and warming uterus, placenta hominis, astragalus membranaceus, codonopsis pilosula, loranthus parasiticus and ligusticum wallichii with functions of tonifying qi and replenishing blood, so that the traditional Chinese medicine composition has the functions of treating both symptoms and root causes of cold-coagulation and blood-stasis type dysmenorrhea and has the effects of warming uterus and replenishing blood; low cost, no toxic side effect and suitability for long-term administration by women.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea and a preparation method thereof.
Background
Dysmenorrhea refers to the condition of pain and distention of the lower abdomen before and after menstruation or during menstruation, accompanied by soreness of the waist or other discomfort, and serious influence on the quality of life. Among them, those with anorganic lesions of the reproductive organs are called primary dysmenorrhea, and are common in young and unproductive women. The disease belongs to the category of abdominal pain during menstruation in traditional Chinese medicine.
The dysmenorrhea is classified into qi stagnation and blood stasis type, cold accumulation and blood stasis type, damp heat and blood stasis type, qi and blood deficiency type and kidney qi deficiency type according to the differentiation of symptoms and signs in the TCM gynecology, wherein the cold accumulation and blood stasis type dysmenorrhea is common and has the etiology of congenital deficiency and body yang deficiency; or in the wet land and tidal zone for a long time, so that cold pathogen can invade the Chong and ren channels; or during menstrual period, the patient is rainy and waded, is greedy to eat and eat raw and cold, and loses yang qi; insufficient yang qi in the body and excessive cold pathogen, the cold pathogen and yang qi in the body are in conflict with each other, blood is cold congealing, so that qi and blood in the body are unsmooth in running, qi and blood flow down the Chong and ren channels during premenstrual period are more stagnated, and the stagnation leads to pain, so that the dysmenorrhea is caused. The symptoms are as follows: cold pain in the lower abdomen before or during menstruation, pain due to heat getting relieved, severe pain due to pressure, scanty menstruation, dark color with lumps in the menstruation, white and greasy tongue coating, deep and tense pulse, aversion to cold and body pain.
Because dysmenorrhea has great influence on the body and spirit of women, normal life, work, study and labor can not be realized during menstrual dysmenorrhea, although various medicines for relieving dysmenorrhea, such as indomethacin, ibuprofen and atropine, are available on the market, and modified Xiaoyao pills, acupuncture and moxibustion and the like are adopted, the medicines and acupuncture and moxibustion and the like can only relieve and relieve pain generally, patients can not be relieved fundamentally, and western medicines have great side effect on human bodies; acupuncture and moxibustion can only relieve temporarily, can not eradicate dysmenorrhea and has long treatment course, so that a traditional Chinese medicine composition without toxic and side effects is needed to be provided.
Disclosure of Invention
Aiming at the situation, in order to make up for the existing defects, the invention provides the traditional Chinese medicine composition for treating the cold-coagulation blood-stasis type dysmenorrhea, which has low cost and addresses both the symptoms and root causes, and the preparation method thereof.
The invention provides the following technical scheme: the invention provides a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea, which comprises the following components in parts by weight: 5-11 parts of motherwort, 3-9 parts of herba lycopi, 2-8 parts of costustoot, 2-6 parts of achyranthes root, 4-10 parts of fennel, 3-7 parts of cinnamon, 3-5 parts of radix angelicae pubescentis, 4-9 parts of human placenta, 3-7 parts of astragalus mongholicus, 3-7 parts of codonopsis pilosula, 2-5 parts of parasitic loranthus and 1-5 parts of ligusticum wallichii.
Preferably, the traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea comprises the following components in parts by weight: 7-9 parts of motherwort, 5-7 parts of herba lycopi, 4-6 parts of costustoot, 3-5 parts of achyranthes root, 6-8 parts of fennel, 4-6 parts of cinnamon, 3.5-4.5 parts of radix angelicae pubescentis, 5-8 parts of human placenta, 4-6 parts of astragalus membranaceus, 4-6 parts of codonopsis pilosula, 3-4 parts of loranthus parasiticus and 2-4 parts of ligusticum wallichii.
Preferably, the traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea comprises the following components in parts by weight: 8 parts of motherwort, 6 parts of herba lycopi, 5 parts of elecampane, 4 parts of radix achyranthis bidentatae, 7 parts of fennel, 5 parts of cinnamon, 4 parts of radix angelicae pubescentis, 6.5 parts of human placenta, 5 parts of radix astragali, 5 parts of codonopsis pilosula, 3.5 parts of parasitic loranthus and 3 parts of ligusticum wallichii.
The invention relates to a preparation method of a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea, which specifically comprises the following steps:
step one, putting the traditional Chinese medicine components into a traditional Chinese medicine pulverizer, pulverizing into powder, and sieving with a 100-mesh sieve;
weighing and fully mixing the powdery traditional Chinese medicine components in parts by weight to obtain a traditional Chinese medicine composition;
and step three, evenly dividing the traditional Chinese medicine composition into independent packages, sealing and storing.
When the Chinese medicinal composition is taken by a patient, the Chinese medicinal composition which is independently packaged is taken out and decocted for drinking.
Motherwort: has the effects of promoting blood circulation, removing blood stasis, regulating menstruation and eliminating water, and has excellent treatment effect on cold-congealing and blood stasis type dysmenorrhea;
herba lycopi: has effects in promoting blood circulation, dispelling blood stasis, inducing diuresis, and relieving swelling, and can be used for treating diseases such as blood stasis, amenorrhea, dysmenorrhea, abdominal mass, puerperal stagnation, abdominal pain, facial edema, traumatic injury, pyocutaneous disease, toxic swelling, edema, and ascites;
costustoot: has effects of activating qi-flowing, relieving pain, invigorating spleen, and can be used for treating anorexia and abdominal distention and pain, dysmenorrhea, menoxenia and puerperal blood stasis;
achyranthes root: has effects in treating blood stasis, amenorrhea, dysmenorrhea, and abdominal pain during menstruation;
fennel: has the effects of pungent and warm property, entering lower energizer, warming liver and kidney, and dispelling cold in uterus;
cinnamon: has the functions of warming kidney, dispelling cold, warming kidney and tonifying yang, and has good treatment effect on dysmenorrhea caused by cold in uterus;
radix angelicae pubescentis: has effects in expelling pathogenic wind, removing dampness, dispelling cold, and relieving pain;
human placenta: has effects of benefiting qi and nourishing blood;
astragalus root: has effects in tonifying blood, invigorating qi, and regulating menstruation;
codonopsis pilosula: has effects in invigorating middle warmer, invigorating qi, and promoting salivation;
parasitic loranthus: has effects in dispelling pathogenic wind, removing dampness, and nourishing blood;
ligusticum wallichii: has effects in promoting blood circulation, activating qi-flowing, dispelling pathogenic wind, and relieving pain.
The invention with the structure has the following beneficial effects: the invention provides a traditional Chinese medicine composition for treating cold-coagulation and blood-stasis type dysmenorrhea and a preparation method thereof, wherein motherwort, herba lycopi, elecampane and achyranthes bidentata with functions of activating blood and removing stasis are adopted to be mutually compatible with fennel, cinnamon and radix angelicae pubescentis with functions of dispelling cold and warming uterus, human placenta with functions of tonifying qi and replenishing blood, astragalus mongholicus, codonopsis pilosula, parasitic loranthus and ligusticum wallichii, so that the traditional Chinese medicine composition has the function of treating both symptoms and root causes of cold-coagulation and blood-stasis type dysmenorrhea, and has the effects of warming uterus and replenishing blood; low cost, no toxic side effect and suitability for long-term administration by women.
Detailed Description
The technical solution of the present invention will be described clearly and completely with reference to the following embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, rather than all of the embodiments; all other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The invention provides the following technical scheme: the invention provides a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea, which comprises the following components in parts by weight: 8 parts of motherwort, 6 parts of herba lycopi, 5 parts of elecampane, 4 parts of radix achyranthis bidentatae, 7 parts of fennel, 5 parts of cinnamon, 4 parts of radix angelicae pubescentis, 6.5 parts of human placenta, 5 parts of radix astragali, 5 parts of codonopsis pilosula, 3.5 parts of parasitic loranthus and 3 parts of ligusticum wallichii.
The invention relates to a preparation method of a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea, which specifically comprises the following steps:
step one, putting the traditional Chinese medicine components into a traditional Chinese medicine pulverizer, pulverizing into powder, and sieving with a 100-mesh sieve;
weighing and fully mixing the powdery traditional Chinese medicine components in parts by weight to obtain a traditional Chinese medicine composition;
and step three, evenly dividing the traditional Chinese medicine composition into independent packages, sealing and storing.
Example 2
The invention provides the following technical scheme: the invention provides a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea, which comprises the following components in parts by weight: 5 parts of motherwort, 3 parts of herba lycopi, 2 parts of elecampane, 2 parts of radix achyranthis bidentatae, 4 parts of fennel, 3 parts of cinnamon, 3 parts of radix angelicae pubescentis, 4 parts of human placenta, 3 parts of astragalus membranaceus, 3 parts of codonopsis pilosula, 2 parts of parasitic loranthus and 1 part of ligusticum wallichii.
The invention relates to a preparation method of a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea, which specifically comprises the following steps:
step one, putting the traditional Chinese medicine components into a traditional Chinese medicine pulverizer, pulverizing into powder, and sieving with a 100-mesh sieve;
weighing and fully mixing the powdery traditional Chinese medicine components in parts by weight to obtain a traditional Chinese medicine composition;
and step three, evenly dividing the traditional Chinese medicine composition into independent packages, sealing and storing.
Example 3
The invention provides the following technical scheme: the invention provides a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea, which comprises the following components in parts by weight: 11 parts of motherwort, 9 parts of herba lycopi, 8 parts of elecampane, 6 parts of radix achyranthis bidentatae, 10 parts of fennel, 7 parts of cinnamon, 5 parts of radix angelicae pubescentis, 9 parts of human placenta, 7 parts of astragalus membranaceus, 7 parts of codonopsis pilosula, 5 parts of parasitic loranthus and 5 parts of ligusticum wallichii.
The invention relates to a preparation method of a traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea, which specifically comprises the following steps:
step one, putting the traditional Chinese medicine components into a traditional Chinese medicine pulverizer, pulverizing into powder, and sieving with a 100-mesh sieve;
weighing and fully mixing the powdery traditional Chinese medicine components in parts by weight to obtain a traditional Chinese medicine composition;
and step three, evenly dividing the traditional Chinese medicine composition into independent packages, sealing and storing.
And (3) clinical trials:
test groups: 30 patients between 18-26 years old, the course of disease is more than 2 years, the traditional Chinese medicine composition provided by the invention is decocted twice a day, decocted for 50 minutes by slow fire, stewed for 30 minutes, continuously taken for 20 days every month and continuously taken for 6 months;
control group: 30 patients aged 18-26 years with disease course of more than 2 years are administered with herba Leonuri granule according to the instruction for 6 months.
The clinical efficacy of the test group and the control group is compared as shown in the following table:
| group of | Number of people | Cure of disease | Show effect | Is effective | Invalidation | Total effective rate |
| Test group | 30 | 10(33.3％) | 12(40％) | 7(23.3％) | 1(3.33％) | 96.7％ |
| Control group | 30 | 5(16.7％) | 10(33.3％) | 5(16.7％) | 10(33.3％) | 66.7％ |
Wherein, curing: refers to the patients who have no relapse after taking the medicine and have no abdominal pain and other symptoms in menstrual period after stopping taking the medicine for 3 months;
the effect is shown: the abdominal pain is obviously relieved, other symptoms are improved, and the symptoms are not aggravated after the medicine is stopped for 3 months;
the method has the following advantages: the abdominal pain is relieved, other symptoms are improved, and the symptoms are relieved after the medicine is stopped but are relieved compared with the symptoms before the treatment;
and (4) invalidation: abdominal pain and other symptoms are unchanged or aggravated.
The comparison clearly shows that the cure rate and symptom improvement rate of the traditional Chinese medicine composition provided by the technical scheme are obviously improved compared with the cure rate and symptom improvement rate of the traditional Chinese medicine composition which is only taken by motherwort particles.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (4)
1. A traditional Chinese medicine composition for treating cold-congealing blood-stasis type dysmenorrhea is characterized by comprising the following components in parts by weight: 5-11 parts of motherwort, 3-9 parts of herba lycopi, 2-8 parts of costustoot, 2-6 parts of achyranthes root, 4-10 parts of fennel, 3-7 parts of cinnamon, 3-5 parts of radix angelicae pubescentis, 4-9 parts of human placenta, 3-7 parts of astragalus mongholicus, 3-7 parts of codonopsis pilosula, 2-5 parts of parasitic loranthus and 1-5 parts of ligusticum wallichii.
2. The traditional Chinese medicine composition for treating cold-congealing and blood-stasis type dysmenorrhea according to claim 1, which is characterized by comprising the following components in parts by weight: 7-9 parts of motherwort, 5-7 parts of herba lycopi, 4-6 parts of costustoot, 3-5 parts of achyranthes root, 6-8 parts of fennel, 4-6 parts of cinnamon, 3.5-4.5 parts of radix angelicae pubescentis, 5-8 parts of human placenta, 4-6 parts of astragalus membranaceus, 4-6 parts of codonopsis pilosula, 3-4 parts of loranthus parasiticus and 2-4 parts of ligusticum wallichii.
3. The traditional Chinese medicine composition for treating cold-congealing and blood-stasis type dysmenorrhea according to claim 1, which is characterized by comprising the following components in parts by weight: 8 parts of motherwort, 6 parts of herba lycopi, 5 parts of elecampane, 4 parts of radix achyranthis bidentatae, 7 parts of fennel, 5 parts of cinnamon, 4 parts of radix angelicae pubescentis, 6.5 parts of human placenta, 5 parts of radix astragali, 5 parts of codonopsis pilosula, 3.5 parts of parasitic loranthus and 3 parts of ligusticum wallichii.
4. A preparation method of the traditional Chinese medicine composition for treating cold-coagulation and blood stasis type dysmenorrhea according to any one of claims 1 to 3, which is characterized by comprising the following steps:
step one, putting the traditional Chinese medicine components into a traditional Chinese medicine pulverizer, pulverizing into powder, and sieving with a 100-mesh sieve;
weighing and fully mixing the powdery traditional Chinese medicine components in parts by weight to obtain a traditional Chinese medicine composition;
and step three, evenly dividing the traditional Chinese medicine composition into independent packages, sealing and storing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111526549.0A CN114177217A (en) | 2021-12-14 | 2021-12-14 | Traditional Chinese medicine composition for treating cold-coagulation and blood stasis type dysmenorrhea and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111526549.0A CN114177217A (en) | 2021-12-14 | 2021-12-14 | Traditional Chinese medicine composition for treating cold-coagulation and blood stasis type dysmenorrhea and preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114177217A true CN114177217A (en) | 2022-03-15 |
Family
ID=80604963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111526549.0A Pending CN114177217A (en) | 2021-12-14 | 2021-12-14 | Traditional Chinese medicine composition for treating cold-coagulation and blood stasis type dysmenorrhea and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114177217A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1430975A (en) * | 2003-01-23 | 2003-07-23 | 上海澳博海洋生物技术开发有限公司 | Extractive of ocean star worm, its preparing method and application |
-
2021
- 2021-12-14 CN CN202111526549.0A patent/CN114177217A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1430975A (en) * | 2003-01-23 | 2003-07-23 | 上海澳博海洋生物技术开发有限公司 | Extractive of ocean star worm, its preparing method and application |
Non-Patent Citations (2)
| Title |
|---|
| 许利平: "《实用中成药手册》", 31 October 2010, 中国中医药出版社 * |
| 边文会等: "补肾温阳化瘀法治疗子宫内膜异位症的临床研究", 《中国全科医学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101732528B (en) | Chinese medicament for treating of hyperplasia of mammary gland | |
| CN103751562A (en) | Traditional Chinese medicine for treating calculus | |
| CN112546178A (en) | Traditional Chinese medicine preparation for treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN101002848B (en) | Medicine for treating recurrent uarthritis, and its preparing method | |
| CN101239134B (en) | Speckle-removing medicinal composition | |
| CN100421687C (en) | Chinese medicine for treating kidney insufficiency | |
| CN114177217A (en) | Traditional Chinese medicine composition for treating cold-coagulation and blood stasis type dysmenorrhea and preparation method | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN102895610A (en) | Medicine for treating edema | |
| CN102370795B (en) | Self-heated traditional Chinese medicine (TCM) emplastrum for treating primary dysmenorrhea | |
| CN100569270C (en) | The medicine of treatment mastalgia | |
| CN106075288A (en) | Bionical hot type Chinese medicine breast pad and application thereof | |
| CN105561211A (en) | External ointment for treating mammary gland inflammation | |
| CN106039151A (en) | External use ointment for treating hyperplasia of mammary glands | |
| CN102228652A (en) | Chinese medicinal composition for treating chronic peritonitis and preparation method thereof | |
| CN101850101B (en) | Chinese medicinal composition for treating metrostaxis and preparation method thereof | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN103211917A (en) | Antler plate wine and preparation method thereof | |
| CN102949668A (en) | Health protection tablet for removing spot and preparation method thereof | |
| CN102793845A (en) | Chinese medicinal composition for treating climacteric syndrome | |
| LU505253B1 (en) | Traditional chinese medicine composition for treating ovarian hypofunction and application thereof | |
| CN105535719A (en) | Medicine composition for treating blood stasis type amenorrhoea | |
| CN105641522A (en) | Traditional Chinese medicine for treating haemorrhoids | |
| CN118178584A (en) | Traditional Chinese medicine composition for tonifying kidney, promoting blood circulation and nourishing fetus | |
| CN117618326A (en) | External application traditional Chinese medicine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220315 |
|
| RJ01 | Rejection of invention patent application after publication |